Haleon projects a gradual revenue and profit growth towards the second half of 2025, despite strong end-year sales in 2024. The company recorded 4-6 per cent projected organic revenue growth, with ...

Shares of Haleon PLC HLN rallied 4.18% to £3.98 Friday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.61% to 8,809.74.

Haleon is one of the largest consumer healthcare companies in the world. Over the last few years, Haleon has achieved a more rationalized operation by divesting multiple non-strategic brands ...

Wide-moat Haleon reported solid fourth-quarter earnings that came largely in line with our expectations. Total sales of GBP 2.8 billion was down 0.3% but was up 6.8% organically with 2.7% from ...

Haleon reported FY24 revenue of £11.23B ($14.19B), down 0.6%, with 5% organic growth. Adjusted operating profit fell 6.5% to £2.50B. 2025 guidance projects 4-6% organic revenue growth, with ...

Good morning, everyone. Welcome to Haleon's Full Year 2024 Q&A call. I'm Jo Russell, Head of Investor Relations. And I'm joined this morning by Brian McNamara, Chief Executive Officer; and Dawn ...

British consumer healthcare group Haleon disappointed investors after the Sensodyne toothpaste maker said 2025 revenue growth would be weighted to the second half of the year, sending shares down ...

(Alliance News) - Haleon PLC on Thursday saw organic sales growth accelerate in the fourth quarter but cautioned growth in 2025 would be weighted to the second-half. Pretax profit rose 17% to GBP1 ...

In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other pharma stocks. Healthcare, which includes numerous businesses that offer patient care ...

Consumer healthcare giant Haleon has reported a strong financial performance for 2024, with organic revenue growth of five per cent. However, revenue declined by 0.6 per cent on a reported basis ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other pharma ...